Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
"The Road Less Traveled: Leveraging an Unconventional Career Path"
Summary
In this episode, Tom Caravela is joined by Marc Bernarducci to explore the evolving role of Medical Science Liaisons. Marc shares insights from his educational journey and transition into the industry, highlighting the significance of networking and tenacity. He emphasizes patience and coachability during job searches and new roles, and discusses the complexities of the MSL position, including learning from mistakes. The conversation shifts to adapting to digital platforms and preparing for the post-COVID landscape, stressing the importance of adaptability. Marc concludes with valuable advice for aspiring MSLs, followed by closing remarks and holiday wishes.
Marc Bernarducci, Sr Medical Science Liaison shares ideas on leveraging an unconventional career path to find success.
In this episode we discuss:
- Marc’s education and where his career began
- What made him want to transition to industry and how did he go about it
- How he landed in medical affairs and why he wanted to be an MSL
- His perspective on “unconventional” career path
- His advice for others who are looking to break into their first MSL role
- His other advice to those that are looking to build a career in Medical Affairs
Medical Science Liaison, Marc Bernarducci, MSL career advice, unconventional career path, transitioning to industry
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary